Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc.（HRMY）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
hrmy · 股价预测 · 13 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 13 位华尔街分析师
Buy
13 位分析师
共识
评级分布
12 个月目标价
High
$50.00
Consensus
$43.00
+32.7% upside
Low
$31.00
Median: $45.5 · Last Close: $32.40
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$43.00
32.7% upside
High Target
$50
54.3%
Low Target
$31
-4.3%
Current Price
$32.40
as of today
Based on analyst price targets, the HRMY stock price prediction for the next 12 months ranges from $31 to $50. The consensus HRMY price forecast of $43.00 implies 32.7% upside from the current price of $32.40.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $33.13 | ↑ 2.26% |
1-day model range: $33.01–$33.26. Peak: $33.26 (+2.26%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $41 | +26.4% |
| 2028 | $47 | +44.7% |
| 2029 | $51 | +56.2% |
| 2030 | $53 | +63.1% |
| 2031 | — | +67.0% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · HRMY · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-08 | Truist Securities | Maintains | Hold→Hold |
| 2026-02-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-25 | Needham | Maintains | Buy→Buy |
| 2026-02-25 | B of A Securities | Maintains | Underperform→Underperform |
| 2026-02-25 | UBS | Maintains | Neutral→Neutral |
| 2026-02-11 | UBS | Downgrade ↓ | Buy→Neutral |
| 2026-01-08 | Truist Securities | Maintains | Buy→Buy |
| 2025-12-01 | Mizuho | Maintains | Outperform→Outperform |
| 2025-11-24 | Needham | Maintains | Buy→Buy |
| 2025-11-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Harmony Biosciences Holdings, Inc. (HRMY) stock. Of the recent 109 rating actions, 2 were upgrades and 5 were downgrades. 13 analysts currently cover HRMY.
分析师推荐趋势
HRMY analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1.0B
↓ 19.9% YoY
Revenue Next Year
$1.1B
↑ 13.7% YoY
EPS This Year
$3.43
EPS Next Year
$4.13
↑ 20.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast HRMY EPS of $3.43 for the current fiscal year, based on estimates from 7 analysts. The HRMY revenue forecast is $1.0B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
HRMY 股价预测由两类独立数据源支撑：来自 13 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。HRMY 的共识目标价为 $43.00（+32.7% 上行空间），分析师共识为 Buy。
HRMY 的短期预测（明日）为 $33.13（+2.26%）。 HRMY 对 2027 年的股价预测均值为 $41。 HRMY 对 2030 年的预测区间为 $51–$55。
Harmony Biosciences Holdings, Inc. 在 NASDAQ 上市，代码 HRMY。HRMY 在 2027 年的整体展望偏积极，在覆盖分析师中约 69% 对应 Buy 共识。
常见问题
HRMY 预测 · 8 个问题根据 13 位华尔街分析师，HRMY 的 12 个月平均目标价为 $43.00，最高 $50.00、最低 $31.00。若有图表，中位目标价可在上方查看。相对当前价 $32.40，隐含约 +32.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.